Sarcoidosis caused by interferon therapy.
Respirology
; 10(4): 535-40, 2005 Sep.
Article
en En
| MEDLINE
| ID: mdl-16135181
ABSTRACT
Interferon alpha (IFN-alpha) is an immunomodulator that is used as an antiviral agent in active chronic viral hepatitis C. IFN therapy can cause an induction or exacerbation of sarcoidosis. Although several reports in the gastroenterology literature have suggested an association between IFN therapy and sarcoidosis, this association has rarely been described elsewhere. A 47-year-old woman developed sarcoidosis after cessation of treatment with IFN and ribavirin for chronic hepatitis C. Her sarcoidosis showed liver, pulmonary and skin involvement. She continues to be monitored regularly in the Department of Pulmonary Diseases without steroid therapy. Her sarcoidosis improved spontaneously. We conclude that patients should be monitored for sarcoidosis during and after IFN therapy.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Antivirales
/
Sarcoidosis
/
Enfermedades de la Piel
/
Interferón-alfa
/
Enfermedades Linfáticas
Tipo de estudio:
Diagnostic_studies
Límite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Respirology
Año:
2005
Tipo del documento:
Article
País de afiliación:
Turquía